QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Medicare Advantage claim processed in less than thirty daysAdditional progress with traditional Medicare claim approvals has ac...

Core News & Articles

Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to...

Core News & Articles

https://sam.gov/opp/09d936af89b2496392773ea6302bda5c/view

Core News & Articles

Lifeward (NASDAQ:LFWD) lowers FY2025 sales outlook from $28.000 million-$30.000 million to $24.000 million-$26.000 million vs $...

Core News & Articles

Rewalk Robotics (NASDAQ:LFWD) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0...

Core News & Articles
Lifeward Names Almog Adar As CFO
08/13/2025 12:18:54

Core News & Articles

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to ...

Core News & Articles

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to ...

Core News & Articles

Lifeward (NASDAQ:LFWD) affirms FY2025 sales outlook from $28.00 million-$30.00 million to $28.00 million-$30.00 million vs $28....

Core News & Articles

Rewalk Robotics (NASDAQ:LFWD) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0...

Core News & Articles

Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injury...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION